News Home
Quick Bites
News Archive
News Channel
Special Features
On AirNewsClassical
School Closings
WKSU Support
Funding for WKSU is made possible in part through support from the following businesses and organizations.

Northeast Ohio Medical University

Levin Furniture

Area Agency on Aging 10B, Inc.

For more information on how your company or organization can support WKSU, download the WKSU Media Kit.

(WKSU Media Kit PDF icon )

Donate Your Vehicle to WKSU

Programs Schedule Make A Pledge Member BenefitsFAQ/HelpContact Us
Health and Medicine

Change in FDA policy fast tracks testing of Alzheimer's drug
But other scientists are unable to reproduce dramatic improvements shown in preliminary tests in Cleveland

Reporter / Host
Jeff St. Clair
Dr. Gary Landeth (right) hopes to prove that Bexarotene can treat Alzheimer’s disease through phase 1 clinical trials. He and then graduate student Paige Cramer started a company called Rexceptor to develop the drug for clinical use.
Courtesy of Jeff St.Clair
Download (WKSU Only)
In The Region:

A promising new treatment for Alzheimer’s disease developed in Cleveland has run into some roadblocks, but backers of a repurposed drug are moving forward with clinical trials.


Other options:
Windows Media / MP3 Download (1:04)

The drug Bexarotene was originally used to treat skin cancer. But Gary Landreth, a neuroscientist at Case Western Reserve University, showed last year that mice bred to have Alzheimer’s disease dramatically improved when given the drug. Now Landreth is ready to test it on people.

He says a recent change in FDA policy allows the drug to be tested on healthy people to determine whether it reduces soluble amyloid beta proteins that are believed to lead to Alzheimer’s.

“The FDA has recognized we now need to treat people who are at risk of Alzheimer’s disease but are cognitively normal, and that changes everything,” Landreth says.

The scientific community, however, is not convinced the drug actually works. Last week, the journal "Science" published independent studies that failed to reproduce Landreth’s dramatic results. However, he says he is still holding out hope his original findings in mice will be validated.

“Proving this mechanism in humans is essential to any subsequent development of the drug,” Landreth says.

Landreth says he could know by the end of the year whether Bexarotene will move on to further testing or join the dozens of other would-be Alzheimer treatments littering the path to a cure.

Listener Comments:

Does anyone have any idea as to what dosage they will be testing?

Posted by: DICKY_DOOO on May 28, 2013 4:05AM
Add Your Comment


E-mail: (not published, only used to contact you about your comment)


Page Options

Print this page

E-Mail this page / Send mp3

Share on Facebook

Stories with Recent Comments

New options in Ohio for secular wedding ceremonies
Hello Mike, I support this action. I was not previously aware of the difficulty couples may encounter in locating officials to serve in their non-religious mar...

Charter reform bill includes controversial change for some teachers
I work for a former White Hat charter school; it was sold to another (for-profit) company this past summer and we were told that they would not pay into STRS/PE...

Bhutanese resettlement has had a big economic impact
Informative especially for nonmembers of North Hill. I appreciate the fact that you mention that the younger generation has an easier time than the elders but t...

Ottawa County Commissioner sworn in as new house member
Congratulations on your new appointment to the Ohio House. I'm certain you will do an outstanding job in your new role representing our district. When you have...

Holden Arboretum opens a new canopy walk and emergent tower
Visited the Holden Arboretum today to witness the incredible work you did constructing the tower and bridges.WOW! Very impressed. Knew the build had to be great...

Local club works to bring back the once-prevalent American elm
I would love to help! Where would I get some of the new Strain so I could plant them?

Four Geauga school districts consider consolidating on the Kent State campus
Berkshire was smart to merge with Ledgemont because it had shrinking enrollment and excess capacity at its high school. Now that Cardinal is dragging its feet ...

Ohio Rep. John Boccieri sworn into office and hopes to look for 'middle ground' with colleagues
Welcome back to the Statehouse, John. You are a terrific representative in the truest sense always representing the people's voice in teh district you serve. ...

Lawmakers call for indefinite freeze on Green Energy standards
It's a shame the Hudson Rep. Chooses to mimic the words of the extreme right senator on his way out to join ALEC when we know the Pope was just here because of...

Copyright © 2015 WKSU Public Radio, All Rights Reserved.

In Partnership With:

NPR PRI Kent State University

listen in windows media format listen in realplayer format Car Talk Hosts: Tom & Ray Magliozzi Fresh Air Host: Terry Gross A Service of Kent State University 89.7 WKSU | NPR.Classical.Other smart stuff. NPR Senior Correspondent: Noah Adams Living on Earth Host: Steve Curwood 89.7 WKSU | NPR.Classical.Other smart stuff. A Service of Kent State University